99% Purity Pharmaceutical Raw Material Bimatoprost for Health Care

Model NO.
TGY022023050503
Shipping Time
Within 3-7 Working Days
Storage
Cool Dry Place
Appearance
White Powder
CAS
155206-00-1
Grade
Pharmaceuticals Grade
Shelf Life
2 Years
Specificcation
99%
Product Name
Bimatoprost
Transport Package
Foil Bag, Box, Drum
Specification
99% min
Trademark
TGY
Origin
China
HS Code
300440906
Production Capacity
150kg/Month
Reference Price
$ 45.00 - 225.00
Contact Us

Product Description


99% Purity Pharmaceutical Raw Material Bimatoprost for Health Care 99% Purity Pharmaceutical Raw Material Bimatoprost for Health Care

Name:Bimatoprost
Synonyms:N-ETHYL-9ALPHA,11ALPHA,15S-TRIHYDROXY-17-PHENYL-18,19,20-TRINOR-PROSTA-5Z, 13E-DIEN-1-AMIDE; ; BIMATOPROST(TM); 17-PHENYL TRINOR PROSTAGLANDIN F2ALPHA ETHYL AMIDE; BIMATOPROST; 17-phenyl-tri-norprostaglandin f2-ethyl amide; (Z)-7-[(1R,2R,3R,5S)-3,5-Dihydroxy-2-[(E,3S)-3-hydroxy-5-phenylpent-1-enyl]cyclopentyl]-N-ethylhept-5-enamide; (5Z)-7-{(1R,2R,3R,5S)-3,5-dihydroxy-2-[(1E,3S)-3-hydroxy-5-phenylpent-1-en-1-yl]cyclopentyl}-N-ethylhept-5-enamide; (5E)-7-{(1R,2R,3R,5S)-3,5-dihydroxy-2-[(1E,3S)-3-hydroxy-5-phenylpent-1-en-1-yl]cyclopentyl}-N-ethylhept-5-enamide
CAS No.:155206-00-1
MF:C25H37NO4
MW:415.5656
Purity:99%
Appearance:White crystal Powder

Bimatoprost (marketed in the U.S., Canada and Europe by Allergan, ) is aprostaglandin analog/prodrug used topically (as eye drops) to control the progression of glaucoma and in the management of ocular hypertension. It reduces intraocular pressure (IOP) by increasing the outflow of aqueous fluidfrom the eyes. In December 2008, the indication to lengthen eyelashes was approved by the U.S. Food and Drug Administration (FDA); the cosmetic formulation of bimatoprost is sold as Latisse In 2008-2011, at least three case series suggested that bimatoprost has the ability to reduce adipose (fat) tissue.

Bimatoprost is a prostaglandin analog used topically (as eye drops) to control the progression of glaucoma and in the management of ocular hypertension. It reduces intraocular pressure (IOP) by increasing the outflow of aqueous fluid from the eyes.
Packing foil bag or as required.

COA of  Bimatoprost:
 

TEST SPECIFICATIONS RESULTS
Appearance White to yellow crystalline powder White crystalline powder
Identification A. Should meet the requirement Conforms
  B. Should meet the requirement Conforms
Impurity A ≤0.5% N.D.
Impurity B ≤0.3% 0.075%
Loss on drying ≤0.5% 0.085%
Residue on Ignition ≤0.1% 0.045%
Residual solvent Eth≤0.5% 0.026%
  Eth≤0.5% N.D.
  Tetra≤0.072% N.D.
Heavy Metal ≤20ppm Conforms
Assay 98.0%~102.0% (Calculated on the dried basis) 99.5%

 

 

Pharmaceutical Intermediate

LEGALIS.IT, 2023